Simson Jake insider trades
Simson Jake has filed 18 Form 4s with the SEC that we hold, for Janux Therapeutics, Inc. (JANX) (Director), Tyra Biosciences, Inc. (TYRA) (Director), Bicara Therapeutics Inc. (BCAX) (Director) and DICE (Director), among 6 companies in all. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-06-08 and the latest 2026-06-30.
Janux Therapeutics, Inc. (JANX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Tyra Biosciences, Inc. (TYRA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Bicara Therapeutics Inc. (BCAX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
DICE
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Septerna, Inc. (SEPN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Parabilis Medicines, Inc. (PBLS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1863094) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms